Abstract
To allocate HIV prevention resources effectively, it is important to have information about the effectiveness of alternative prevention programs as a function of expenditure. We refer to this relationship as the “production function” for a prevention program. Few studies of HIV prevention programs have reported this relationship. This paper demonstrates the value of such information. We present a simple model for allocating HIV prevention resources, and apply the model to an illustrative HIV prevention resource allocation problem. We show that, without sufficient information about prevention program production functions, suboptimal decisions may be made. We show that epidemiologic data, such as estimates of HIV prevalence or incidence, may not provide enough information to support optimal allocation of HIV prevention resources. Our results suggest that good allocations can be obtained based on fairly basic information about prevention program production functions: an estimate of fixed cost plus a single estimate of cost and resulting risk reduction. We find that knowledge of production functions is most important when fixed cost is high and/or when the budget is a significantly constraining factor. We suggest that, at the minimum, future data collection on prevention program effectiveness should include fixed and variable cost estimates for the intervention when implemented at a “typical” level, along with a detailed description of the intervention and detailed description of costs by category.
Similar content being viewed by others
References
N.J. Bailey,The Mathematical Theory of Infectious Diseases and Its Applications (Hafner Press, New York, 1975).
M.L. Brandeau, G.S. Zaric and A. Richter, Optimal resource allocation for epidemic control among multiple independent populations: Beyond cost effectiveness analysis. Journal of Health Economics 22(4) (2003) 575–598.
R.E. Booth, C.F. Kwiatkowski and R.C. Stephens, Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users, Journal of Psychoactive Drugs 30(3) (1998) 269–278.
S.L. Coyle, R.H. Needle and J. Normand, Outreach-based HIV prevention for injecting drug users: A review of published outcome data, Public Health Reports 113 (Suppl 1) (1998) 19–30.
D.M. Edwards, R.D. Shachter and D.K. Owens, A dynamic HIV-transmission model for evaluating the costs and benefits of vaccine programs, Interfaces 28(3) (1998) 144–166.
A. Edwards, et al., The effectiveness of one-to-one risk communication interventions in health care: A systematic review, Medical Decision Making 20(3) (2000) 290–297.
A.R. Elwy, et al., Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men: A systematic review, Archives of Internal Medicine 162 (16) (2002) 1818–1830.
M. Facer, et al.,Consensus Meeting on HIV/AIDS Incidence and Prevalence in California, (California Department of Health Services, Office of AIDS: Sacramento, 2001).
W.D. Johnson, L.V. Hedges and R.M. Diaz, Interventions to modify sexual risk behaviors for preventing HIV infection in men who have sex with men (Cochrane Review), Cochrane Database Systems Review 1 (2003) CD001230.
W.D. Johnson, et al., HIV prevention research for men who have sex with men: A systematic review and meta-analysis, Journal of Acquired Immune Deficiency Syndrome, 30 (Suppl 1) (2002) S118-S129.
A.P. Johnson-Masotti, et al., Decision making in HIV prevention community planning: An integrative review, Journal of Community Health 25(2) (2000) 95–112.
J.G. Kahn, The cost-effectiveness of HIV prevention targeting: How much more bang for the buck? American Journal of Public Health 86(12) (1996) 1709–1712.
E.H. Kaplan, Economic analysis of needle exchange. AIDS 9(10), (1995) 1113–1119.
E.H. Kaplan, Economic evaluation and HIV prevention community planning: A policy analyst’s perspective, inHandbook of Economic Evaluation of HIV Prevention Programs, ed. D.R. Holtgrave (Plenum Press, New York, 1998) pp. 177–193.
E.H. Kaplan and E. O’Keefe, Let the needles do the talking! Evaluating the New Haven needle exchange, Interfaces 23(1) (1992) 7–26.
E.H. Kaplan and H. Pollack, Allocating HIV prevention resources, Socio-Economic Planning Sciences 32(4) (1998) 257–263.
N. Kim, et al., Effectiveness of the 40 adolescent AIDS-risk reduction interventions: A quantitative review, Journal of Adolescent Health 20(3) (1997) 204–215.
L. Kotranski, et al., Effectiveness of an HIV risk reduction counseling intervention for out-of-treatment drug users, AIDS Education and Prevention 10(1) (1998) 19–33.
P.D. Mullen, et al., Meta-analysis of the effects of behavioral HIV prevention interventions on the sexual risk behavior of sexually experienced adolescents in controlled studies in the United States, Journal of Acquired Immune Deficiency Syndrome 30(Suppl 1) (2002) S94-S105.
M.S. Neumann, et al., Review and meta-analysis of HIV prevention intervention research for heterosexual adult populations in the United States, Journal of Acquired Immune Deficiency Syndrome 30 (Suppl 1) (2002) S106–S17.
A. Richter, M.L. Brandeau and D.K. Owens, An analysis of optimal resource allocation for HIV prevention among injection drug users and nonusers, Medical Decision Making 19(2) (1999) 167–179.
M.S. Ruiz, et al.,No Time To Lose: Getting More from HIV Prevention (National Academy Press, Washington, DC, 2001).
S. Semaan, et al., A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction, Journal of Acquired Immune Deficiency Syndrome 30 (Suppl 1) (2002) S30–S50.
S. Semaan, et al., A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States, Journal of Acquired Immune Deficiency Syndrome, 30 (Suppl 1) (2002) S73–S93.
A.A. Stinnett and A.D. Paltiel, Mathematical programming for the efficient allocation of health care resources, Journal of Health Economics 15 (1996) 641–653.
UNAIDS/WHO,AIDS Epidemic Update: December 2002. 2002, Joint United Nations Programme on HIV/AIDS and World Health Organization: Geneva, Switzerland.
US Bureau of the Census,Statistical Abstract of the United States, (US Bureau of the Census: Washington, DC, 2002).
A. Wilson and J. Kahn, Preventing HIV in injection drug users: Choosing the best mix of interventions for the population, Journal of Urban Health 80(3) (2003) 465–481.
A. Wilson and J. Kahn, Preventing HIV in injection drug users: Exploring the tradeoffs between interventions, Socio-Economic Planning Sciences 37(4) (2003) 269–288.
G.M. Wingood and R.J. DiClemente, HIV sexual risk reduction interventions for women: A review, American Journal of Preventive Medicine 12(3) (1996) 209–217.
G.S. Zaric and M.L. Brandeau, Optimal investment in a portfolio of HIV prevention programs, Medical Decision Making 21 (2001) 391–408.
G.S. Zaric and M.L. Brandeau, Resource allocation for epidemic control over short time horizons, Mathematical Biosciences 171 (2001) 33–58.
G.S. Zaric, P.G. Barnett and M.L. Brandeau, HIV transmission and the cost effectiveness of methadone maintenance, American Journal of Public Health 90 (2000) 1100–1111.
G.S. Zaric, M.L. Brandeau and P.G. Barnett, Methadone maintenance and HIV prevention: A cost-effectiveness analysis, Management Science 46 (2000) 1013–1031.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brandeau, M.L., Zaric, G.S. & De Angelis, V. Improved Allocation of HIV Prevention Resources: Using Information About Prevention Program Production Functions. Health Care Manage Sci 8, 19–28 (2005). https://doi.org/10.1007/s10729-005-5213-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10729-005-5213-6